Communicating Value of Personalized Medicine to All Stakeholders in Healthcare

Sanjiv S. Agarwala, MD

Video Categories: Value

Listen as Dr Argawala articulates the value proposition of personalized medicine for all stakeholders in healthcare.
October 7, 2016

Common Issues in Treating Patients with HR+/ HER2-Negative Metastatic Breast Cancer

Dr Hope Rugo discusses some of the choices and challenges she’s faced with in treating patients with HR+/ HER2-negative metastatic breast cancer with the goal of helping patients live as long as possible and with the best quality of life.

September 2, 2015

Aspirations for the Launch of Ixazomib

Ixazomib may have the potential for great combinability with other drugs, according to Dixie-Lee Esseltine, MD and George Mulligan, PhD. Combination therapy improves compliance, adherence, and quality of life among patients.